- Record: Senate Floor
- Section type: Recognition
- Chamber: Senate
- Date: May 21, 2026
- Congress: 119th Congress
- Why this source matters: This section came from the Senate floor portion of the record.
SENATE RESOLUTION 751—DESIGNATING MAY 2026 AS “ALS AWARENESS MONTH”
Mr. COONS (for himself, Ms. Murkowski, Mr. Whitehouse, and Mr. Cotton) submitted the following resolution; which was referred to the Committee on the Judiciary:
S. Res. 751
Whereas amyotrophic lateral sclerosis (referred to in this
preamble as “ALS”) is a progressive neurodegenerative
disease that affects nerve cells in the brain and the spinal
cord;
Whereas the life expectancy for an individual with ALS is
between 2 and 5 years after the date on which the individual
receives an ALS diagnosis;
Whereas ALS occurs throughout the world with no racial,
ethnic, gender, or socioeconomic boundaries;
Whereas ALS may affect any individual in any location;
Whereas the cause of ALS is unknown in up to 90 percent of
cases;
Whereas approximately 10 percent of ALS cases have a strong
known genetic driver;
Whereas, on average, the period between the date on which
an individual first experiences symptoms of ALS and the date
on which the individual is diagnosed with ALS is more than 1
year;
Whereas the onset of ALS often involves muscle weakness or
stiffness, and the progression of ALS results in the further
weakening, wasting, and paralysis of—
(1) the muscles of the limbs and trunk; and
(2) the muscles that control vital functions, such as
speech, swallowing, and breathing;
Whereas ALS can strike individuals of any age, but it
predominantly strikes adults;
Whereas it is estimated that tens of thousands of
individuals in the United States have ALS at any given time;
Whereas, based on studies of the population of the United
States, more than 5,000 individuals in the United States are
diagnosed with ALS each year, and 15 individuals in the
United States are diagnosed with ALS each day;
Whereas, every 90 minutes, someone dies from ALS or is
diagnosed with ALS in the United States;
Whereas the majority of individuals with ALS die of
respiratory failure;
Whereas, in the United States, military veterans are more
likely to be diagnosed with ALS than individuals with no
history of military service;
Whereas, as of the date of introduction of this resolution,
there is no cure for ALS;
Whereas the spouses, children, and family members of
individuals living with ALS provide support to those
individuals with love, day-to-day care, and more; and
Whereas an individual with ALS, and the caregivers of such
an individual, can be required to bear significant costs for
medical care, equipment, and home care services for the
individual as the disease progresses: Now, therefore, be it
Resolved, That the Senate—
(1) designates May 2026 as “ALS Awareness Month”;
(2) affirms the dedication of the Senate to—
(A) ensuring individuals with amyotrophic lateral sclerosis
(referred to in this resolution as “ALS”) have access to
effective treatments and high-quality services and supports
as early as possible after diagnosis;
(B) identifying risk factors and causes of ALS to prevent
new cases;
(C) empowering individuals with ALS to maintain their
personal independence to the maximum extent possible; and
(D) reducing the physical and emotional burdens of living
with ALS; and
(3) commends the dedication of the family members, friends,
organizations, volunteers, researchers, and caregivers across
the United States who are working to improve the quality and
length of life of ALS patients and develop treatments and
cures that reach patients as soon as possible.